The drug-binding activity of the multidrug-responding transcriptional regulator BmrR resides in its C-terminal domain
- 1 March 1996
- journal article
- research article
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 178 (5) , 1473-1475
- https://doi.org/10.1128/jb.178.5.1473-1475.1996
Abstract
Rhodamine and tetraphenylphosphonium, the substrates of the Bacillus subtilis multidrug efflux transporter Bmr, induce the expression of Bmr through direct interaction with its transcriptional activator BmrR. Here we show that the C-terminal domain of BmrR, expressed individually, binds both these compounds and therefore can be used as a model for molecular analysis of the phenomenon of multidrug recognition.Keywords
This publication has 10 references indexed in Scilit:
- Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulatedJournal of Bacteriology, 1995
- A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates.Journal of Biological Chemistry, 1994
- Expression and Purification of Thioredoxin Fusion ProteinsCurrent Protocols in Molecular Biology, 1994
- Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active EffluxScience, 1994
- Multidrug resistance pumps in bacteria: variations on a themeTrends in Biochemical Sciences, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- A Thioredoxin Gene Fusion Expression System That Circumvents Inclusion Body Formation in the E. coli CytoplasmNature Biotechnology, 1993
- Untwist and shout: a heavy metal-responsive transcriptional regulatorJournal of Bacteriology, 1992
- Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system.Proceedings of the National Academy of Sciences, 1991
- The MerR Metalloregulatory Protein Binds Mercuric Ion as a Tricoordinate, Metal-Bridged DimerScience, 1990